Scott Juda, Director at Inmune Bio, Inc. (INMB), bought 29,603 shares at $8.32 ($246K) on 2024-04-19, disclosed to the SEC on 2024-04-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| INMB | BUY | 2021-11-17 | $34K | — | Filing → |
| INMB | BUY | 2019-08-22 | $30K | — | Filing → |
| INMB | BUY | 2019-06-04 | $60K | — | Filing → |